Efficacy and Safety of Ultrase MT20 in Children with CF and Pancreatic Insufficiency
Number of Participants Being Recruited:
Single / Multi-Center:
STUDY BACKGROUND INFORMATION:
This study is being conducted to demonstrate the efficacy and safety of ULTRASE MT20 in children with CF and pancreatic insufficiency, following the new FDA guidelines.
7 Years - 11 Years
P. aeruginosa status:
B. cepacia status:
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
University of Michigan Health System (Pediatric), Ann Arbor, MI, 48109
Kruse, Dawn Phone: (734) 615-3266 Email: firstname.lastname@example.org
University Hospitals Case Medical Center/Rainbow Babies and Children's Hospital (Pediatric), Cleveland, OH, 44106
Ksenich, Roberta (Bobbi) Phone: (216) 844-5733 Email: Roberta.Ksenich@UHHospitals.org
Hershey Medical Center Pennsylvania State University (Pediatric), Hershey, PA, 17033
Kitch, Diane Phone: (717) 531-5646 Email: email@example.com